RGEN REPLIGEN CORP revenue, earnings and financials

For the quarter ended June 30, 2026, REPLIGEN CORP reported revenue of $204M (up 11.9% from a year earlier), net income of $5.01M and diluted EPS of $0.09; over the last four quarters revenue was $785M and net income $41.5M; for the fiscal year ended December 2025 revenue was $738M, up 16.4% on the year before.

RGEN annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $738M, gross profit n/a, operating income $55.2M, net income $48.9M (margin 6.6%), EPS $0.86
• Fiscal year ended Dec 2024: revenue $634M, gross profit n/a, operating income −$35.1M, net income −$25.5M (margin -4.0%), EPS −$0.46
• Fiscal year ended Dec 2023: revenue $632M, gross profit n/a, operating income $47.7M, net income $35.6M (margin 5.6%), EPS $0.63
• Fiscal year ended Dec 2022: revenue $802M, gross profit n/a, operating income $225M, net income $186M (margin 23.2%), EPS $3.24
• Fiscal year ended Dec 2021: revenue $671M, gross profit n/a, operating income $167M, net income $128M (margin 19.1%), EPS $2.24

RGEN quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $204M (up 11.9% year over year), net income $5.01M, EPS $0.09
• Quarter ended Mar 31, 2026: revenue $194M (up 14.8% year over year), net income $8.33M, EPS $0.15
• Quarter ended Dec 31, 2025 (from the annual report): revenue $198M (up 18.1% year over year), net income $13.3M, EPS $0.24
• Quarter ended Sep 30, 2025: revenue $189M (up 21.9% year over year), net income $14.9M, EPS $0.26
• Quarter ended Jun 30, 2025: revenue $182M (up 14.8% year over year), net income $14.9M, EPS $0.26
• Quarter ended Mar 31, 2025: revenue $169M (up 10.4% year over year), net income $5.83M, EPS $0.10
• Quarter ended Dec 31, 2024 (from the annual report): revenue $168M (up 0.6% year over year), net income −$33.9M, EPS −$0.61
• Quarter ended Sep 30, 2024: revenue $155M (up 9.7% year over year), net income −$654K, EPS −$0.01
• Quarter ended Jun 30, 2024: revenue $159M (down 0.2% year over year), net income $5.71M, EPS $0.10
• Quarter ended Mar 31, 2024: revenue $153M (down 7.4% year over year), net income $3.30M, EPS $0.06
• Quarter ended Dec 31, 2023 (from the annual report): revenue $167M (down 10.8% year over year), net income −$16.5M, EPS −$0.29
• Quarter ended Sep 30, 2023: revenue $141M (down 29.7% year over year), net income $16.9M, EPS $0.30
• Quarter ended Jun 30, 2023: revenue $159M (down 23.3% year over year), net income $19.8M, EPS $0.35
• Quarter ended Mar 31, 2023: revenue $165M (down 19.9% year over year), net income $15.3M, EPS $0.27
• Quarter ended Dec 31, 2022 (from the annual report): revenue $187M (up 0.1% year over year), net income $48.7M, EPS $0.84
• Quarter ended Sep 30, 2022: revenue $201M (up 12.6% year over year), net income $40.4M, EPS $0.71
• Quarter ended Jun 30, 2022: revenue $208M (up 27.4% year over year), net income $49.9M, EPS $0.88
• Quarter ended Mar 31, 2022: revenue $206M (up 44.5% year over year), net income $47.0M, EPS $0.81
• Quarter ended Dec 31, 2021 (from the annual report): revenue $187M, net income $29.1M, EPS $0.50
• Quarter ended Sep 30, 2021: revenue $178M, net income $33.5M, EPS $0.58

RGEN cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $117M, share buybacks $0
• Fiscal year ended Dec 2024: operating cash flow $175M, share buybacks $0
• Fiscal year ended Dec 2023: operating cash flow $114M, share buybacks $14.4M
• Fiscal year ended Dec 2022: operating cash flow $172M, share buybacks $0
• Fiscal year ended Dec 2021: operating cash flow $119M, share buybacks $0

RGEN balance sheet

• Jun 30, 2026: cash $607M, total assets $2.95B, total liabilities $838M, shareholders' equity $2.11B
• Mar 31, 2026: cash $583M, total assets $2.93B, total liabilities $825M, shareholders' equity $2.11B
• Dec 31, 2025: cash $566M, total assets $2.95B, total liabilities $844M, shareholders' equity $2.11B
• Sep 30, 2025: cash $749M, total assets $2.92B, total liabilities $841M, shareholders' equity $2.08B
• Jun 30, 2025: cash $709M, total assets $2.90B, total liabilities $840M, shareholders' equity $2.06B
• Mar 31, 2025: cash $697M, total assets $2.85B, total liabilities $867M, shareholders' equity $1.99B
• Dec 31, 2024: cash $757M, total assets $2.83B, total liabilities $857M, shareholders' equity $1.97B
• Sep 30, 2024: cash $784M, total assets $2.83B, total liabilities $814M, shareholders' equity $2.02B

What is RGEN's revenue?

REPLIGEN CORP reported $785M of revenue over its last four quarters, through June 30, 2026.

Is RGEN profitable?

Yes. REPLIGEN CORP earned $41.5M over the last four quarters.

What is RGEN's EPS?

Diluted earnings per share over the last four quarters were $0.74; $0.09 in the latest quarter.

RGEN ownership and insider trades · All stocks